The Food and Drug Administration (FDA) is pressuring manufacturers of generic opioid painkillers to reformulate their meds to make them more difficult to tamper with and abuse, the latest step in the agency’s fight to curb the national prescription drug abuse epidemic. The draft guidance encourages generic drug makers to develop their pain medications with abuse-deterrent properties to help prevent certain types of abuse, such as crushing a tablet in order to snort, or dissolving a capsule in order to inject its contents. Abuse-deterrent formulations do not prevent abuse, addiction, overdose or death, the agency pointed out, but they could have ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.